Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care - 18/10/18
, Ellyn Kodroff b, 1, Mary J. Strobel c, 1, Melissa Scott d, 1, Wendy Book c, Cathy Reidy d, Shay Kyle b, Denise Mack c, Kathleen Sable c, Pablo Abonia e, Jonathan Spergel f, Sandeep K. Gupta g, T. Glenn Furuta h, Marc E. Rothenberg e, Evan S. Dellon iBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 11 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Eosinophilic gastrointestinal disorders (EGID) are group of rare but pose significant burden worldwide. |
• | Patient advocacy groups have an important role in representing the EGID community. |
• | This is the first study to use online portal to study unmet needs and barriers experienced by individuals affected by EGIDs. |
• | Our results reveal that individuals affected by EGIDs have a constellation of complex unmet needs and perceived barriers across medical, healthcare, social and emotional domains. |
• | Understanding unmet needs and barriers will likely guide us to design EGID patient-centered approaches to improve their care and clinical outcomes. |
Summary |
Introduction |
Eosinophilic gastrointestinal disorders (EGIDs) are a rare but emerging healthcare problem. Patient advocacy groups (PAGs) have an important role in representing the EGID community, and serve as valuable research partners. By leveraging the partnership between medical researchers and PAGs, we examined the unmet needs and barriers to care perceived by individuals affected by EGIDs. Next, we examined if these varied between adult EGID patients and adult caregivers of children with EGID.
Methods |
Adult EGID patients and adult caregivers of children (<18 years) with EGIDs participated in this study. PAGs conducted focus groups comprised of individuals affected by EGIDs to identify domains and questions meaningful to the EGID community and this information was used to develop an online REDCap survey. The survey consisted of 58 questions across medical, healthcare, social, and emotional impact domains. It was distributed via the PAGs’ web-based platforms. Demographic data, and responses to questions on a six-point Likert scale were collected and analyzed.
Results |
Of the 361 responses analyzed, 90 (25%) were from adult EGID patients and 271 (75%) were from adult caregivers. Of the applicable responses, in the medical domain only 19% of participants indicated that repeated endoscopies to monitor response to treatment was convenient. In the healthcare domain, 67% indicated that lack of insurance coverage for elemental formula was a barrier. In the social domain, only 5% of respondents reported adequate awareness of EGIDs in schools. In the emotional domain, 64% had experienced significant stress due to EGID related out-of-pocket costs. Multivariate logistic regression revealed that some of these responses varied between adult EGID patients and adult caregivers of children with EGID. The respondents indicated highest priority for improvement in the medical domain compared to other domains.
Conclusions |
Individuals affected by EGIDs have a constellation of complex unmet needs and perceived barriers across medical, healthcare, social and emotional domains. Addressing unmet needs in the medical domain is relatively more important for the EGID community. Understanding unmet needs and barriers will likely help design improved patient-centered EGID care paradigms.
Le texte complet de cet article est disponible en PDF.Keywords : Rare diseases, Eosinophilic gastrointestinal disorders, Eosinophilic esophagitis, Eosinophilic gastritis, Eosinophilic gastroenteritis, Unmet needs, Survey, Healthcare barriers, Health services research, Health promotion
Plan
Vol 42 - N° 5
P. 483-493 - octobre 2018 Retour au numéro
Article précédent
- Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer
- Qianjun Li, Gang Ma, Suhua Sun, Ying Xu, Bingjian Wang
- The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial
- Agnieszka Wegner, Aleksandra Banaszkiewicz, Jaroslaw Kierkus, Piotr Landowski, Anna Korlatowicz-Bilar, Sabina Wiecek, Jaroslaw Kwiecien, Agnieszka Gawronska, Lukasz Dembinski, Grazyna Czaja-Bulsa, Piotr Socha
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?